The Consumer Medicine Information (CMI) is a leaflet that contains information on the safe and effective use of a prescription or specified over-the-counter medicine.
Consumer Medicine Information (CMI) documents are leaflets that contain information on the safe and effective use of a prescription medicine, as well as some non-prescription medicines and some biologicals.
View CMI documents
CMI documents can be found by searching this website or by using the CMI database in eBusiness Services.
Enter the product name, licence details, sponsor details, active ingredient names or the ARTG number to get results.
A CMI document is written by the pharmaceutical company (sponsor) responsible for the medicine.
CMIs are important because they provide information aimed at bringing about better health outcomes.
CMI documents include:
Name of the medicine
Names of the active and inactive ingredients
Dosage of the medicine
What the medicine is used for and how it works
Warnings and precautions, such as when the medicine should not be taken
Interactions the medicine might have with food or other medicines
How to use the medicine properly
Side effects
What to do in the case of an overdose
How to store the medicine properly
Name and address of the sponsor
Date the CMI was last updated.
Availability of CMI documents
CMI documents may not be available for every product.
Sponsors are required to provide CMIs prior to prescription medicines, some non-prescription medicines and some biologicals being released to the market.
Products registered but not yet released to the market will not have accompanying CMI documents.
For medicines that with CMIs, the sponsor is required to make it available to consumers either in the pack or in another manner to enable the information to reach the people who are to receive the medicine.